Results 121 to 130 of about 36,198 (299)

Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction [PDF]

, 2018
Background: Information on the pathophysiological differences between heart failure with reduced ejection fraction (HFrEF) versus heart failure with preserved ejection fraction (HFpEF) is needed Objectives: The purpose of this study was to establish ...
Anker, Stefan D., Cleland, John G. F., Dickstein, Kenneth, Filippatos, Gerasimos S., Hillege, Hans L., Lang, Chim, Metra, Marco, Ng, Leong Loke, Ouwerkerk, Wouter, Ponikowski, Piotr, Samani, Nilesh J., Tromp, Jasper, van der Harst, Pim, van der Meer, Peter, van Veldhuisen, Dirk Jan, Voors, Adriaan A., Westenbrink, Daan, Zannad, Faiez, Zwinderman, Aelko H.   +18 more
core   +3 more sources

Hypertension, diastolic stress test, and HFpEF: Does new scoring system change something? [PDF]

, 2019
Marijana Tadić, Cesare Cuspidi
openalex   +1 more source

Lessons Learned from Community Studies of HFpEF – The Digitalis Study [PDF]

, 2022
Eduarda Corrêa Maia, Evandro Tinoco Mesquita, Antônio José Lagoeiro Jorge, Luiz Cláudio Danzmann   +3 more
openalex   +1 more source

Can HFpEF and HFrEF Coexist? [PDF]

Circulation, 2020
Gabriele G. Schiattarella, Dan Tong, Joseph A. Hill   +2 more
openaire   +3 more sources

Semaglutide normalizes increased cardiomyocyte calcium transients in a rat model of high fat diet‐induced obesity

ESC Heart Failure, Volume 12, Issue 2, Page 1386-1397, April 2025.
Sequeira et al. reveal how the glucagon‐like peptide‐1 receptor agonist (GLP‐1‐RA) semaglutide restores cardiomyocyte function in rats subjected to a high‐fat/high‐fructose diet (HFD). Employing fluorescence‐ and patch‐clamp technology in isolated cardiac myocytes, they demonstrate that semaglutide reverses HFD‐induced activation of L‐type calcium ...
Vasco Sequeira, Julia Theisen, Katharina J. Ermer, Marie Oertel, Anton Xu, David Weissman, Katharina Ecker, Jan Dudek, Martin Fassnacht, Alexander Nickel, Michael Kohlhaas, Christoph Maack, Ulrich Dischinger   +12 more
wiley   +1 more source

Evaluation of Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction (HFpEF)　― Is It Possible to Delineate the Phenotype of HFpEF? ―

, 2021
Chisato Izumi
openalex   +2 more sources

Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi, Alvin Chandra, Ambarish Pandey, Marco Metra   +3 more
wiley   +1 more source

A Delphi consensus project to capture experts' opinion on hyperkalaemia management across the cardiorenal spectrum

ESC Heart Failure, Volume 12, Issue 2, Page 1132-1140, April 2025.
Abstract The main purpose of this project was to capture experts' opinion on hyperkalaemia management and form best practice recommendations for cardiorenal patients in Greece. A steering committee of nephrologists and cardiologists developed 37 statements. An online questionnaire completed by 32 experts in cardiorenal management in Greece.
Christina Chrysohoou, Maria Marketou, Maria Aktsiali, Ioannis Griveas   +3 more
wiley   +1 more source

Heart failure : studies of prognosis and advanced therapy [PDF]

, 2017
Background Heart failure (HF) is a major health problem affecting 2-3% of the Western population. The clinical syndrome of HF is associated with reduced (HFrEF) or preserved (HFpEF) ejection fraction.
Thorvaldsen, Tonje
core   +1 more source

Heart failure with preserved ejection fraction (HFpEF): phenotypes, diagnostic algorithms, and new therapeutic options

Cardiologia Hungarica
Heart failure (HF) is currently one of the most important public health problems. Heart failure with preserved ejection fraction (HFpEF) is a highly heterogeneous disease characterized by normal or near-normal left ventricular ejection fraction ...
Arnold Péter Ráduly, Máté Balázs Kovács, Máté Balázs Kovács, Attila Borbély   +3 more
doaj   +1 more source